미국 프리마켓 특징주, 이슈 • $NVDA +0.30% : 중국, 빠르면 이번 분기 내 일부 H200 칩 구매 승인 예정 • $JEF -2.75% : 실적은 호조였으나, 투자자들은 First Brands 익스포저 관련 손실에 주목 • $STZ +2.0% : 시장 예상 상회 실적 발표 • $APLD +4.6% : 조정 EPS 및 매출 모두 예상치 상회 • $RTX +4.5% / $LMT +7.9% / $NOC +8.4% : 트럼프, 국방 예산을 기존 1.0조 달러 → 1.5조 달러로 증액해야 한다고 발언 • $ABBV -1.1% : 연간 조정 EPS 가이던스 하향 : $RVMD -7.3%, 인수설 부인 영향 • $GOOGL +1.1% : Cantor Fitzgerald, 투자의견 ‘중립’ → ‘비중확대’ 상향 • $MQ -9.5% : Mizuho, 투자의견 ‘시장수익률 상회’ → ‘중립’ 하향 • $AA -4.0% : JPMorgan, 투자의견 ‘중립’ → ‘비중축소’ 하향 • $NKE -1.1% : Needham, 투자의견 ‘매수’ → ‘보유’ 하향 MTS, @MSX_CN 로 국장, 미장 깔짝깔짝

SECTOR NEWS CONSUMER 🔸 $STZ: Q4 EPS $2.63 (est. $2.29); sales +1.2% to $2.16B (est. $2.13B). Beer sales in line, wine/spirits beat. Selling mainstream wine brands to The Wine Group. FY28 EPS growth seen low to mid-single digits. New $4B buyback plan. 🔸 $GM: Downgraded to Neutral from Buy at UBS; target cut to $51 from $64 due to tariff impact. 🔸 $KMX: Q4 EPS $0.58 (est. $0.65); retail used sales +6.2%, comps +5.1%, wholesale units +3.1%. Revenue $6.0B (est. $5.963B). 🔸 $PSMT: Q2 EPS $1.45 (est. $1.40); sales $1.335B (est. $1.359B); comps +6.7%. 🔸 $BKE: March comps +3.7%, net sales +4.5% to $109.1M. ENERGY, INDUSTRIALS & MATERIALS 🔸 $X: Shares fell after Trump opposed Nippon Steel’s takeover. 🔸 $VALE: Upgraded to Buy at Bank of America. FINANCIALS 🔸 $AB: AUM fell to $784B in March from $805B in Feb. 🔸 $CBOE: Downgraded to Neutral at Bank of America. 🔸 $LAZ: March AUM $227.4B; net outflows $3.1B, market loss $5.4B. 🔸 $VCTR: Total client assets $171.4B as of March. HEALTHCARE 🔸 $IDYA: Started Phase 1/2 expansion trial combining IDE397 with Gilead’s Trodelvy. 🔸 $KROS: Shares rise after adopting poison pill; exploring strategic options, including sale. TECHNOLOGY, MEDIA & TELECOM 🔸 $AMZN: 2024 revenue +11% to $638B; AWS +19% to $108B; operating income +86% to $68.6B. 🔸 $ASYS: Cuts Q2 revenue forecast to $15M–$16M (from $21M–$23M) due to customer dispute. 🔸 $TSM: Q1 sales +42% to $25.6B, in line with guidance despite earthquake impact.

#Downgrades - Oct 08, 2024 $ALB: CFRA Downgrades to Hold from Buy - PT $99 $AXP: HSBC Downgrades to Hold from Buy $AXP: BTIG Downgrades to Sell from Neutral - PT $230 $BUD: TD Cowen Downgrades to Hold from Buy - PT $68 $CME: Redburn-Atlantic Downgrades to Neutral from Buy - PT $244 $FYBR: TD Cowen Downgrades to Hold from Buy - PT $38.50 (from $39) $MSFT: Oppenheimer Downgrades to Perform from Outperform $OMF: Barclays Downgrades to Equalweight from Overweight - PT $46 (from $52) $OTIS: Wolfe Research Downgrades to Peerperform from Outperform $QCOM: KeyBanc Downgrades to Sector Weight from Overweight $STZ: TD Cowen Downgrades to Hold from Buy - PT $270 (from $300) $SYNA: KeyBanc Downgrades to Sector Weight from Overweight